| Literature DB >> 29743109 |
Annika Kruse1, Christian Schranz2, Markus Tilp3, Martin Svehlik2.
Abstract
BACKGROUND: Early detection of changes at the muscular level before a contracture develops is important to gain knowledge about the development of deformities in individuals with spasticity. However, little information is available about muscle morphology in children with spastic diplegic cerebral palsy (CP) without contracture or equinus gait. Therefore, the aim of this study was to compare the gastrocnemius medialis (GM) and Achilles tendon architecture of children and adolescents with spastic CP without contracture or equinus gait to that of typically developing (TD) children.Entities:
Keywords: Achilles tendon; Diplegic; Gastrocnemius medialis; Muscle fascicle; Ultrasonography
Mesh:
Year: 2018 PMID: 29743109 PMCID: PMC5941654 DOI: 10.1186/s12887-018-1129-4
Source DB: PubMed Journal: BMC Pediatr ISSN: 1471-2431 Impact factor: 2.125
Anthropometrics, ankle joint, and muscle-tendon parameters of children with cerebral palsy and typically developing peers
| CP ( | TD ( | Effect size | |
|---|---|---|---|
| Age (years) | 12.0 (2.8) | 11.3 (2.5) | |
| Body mass (kg) | 45.2 (19.1) | 44.8 (15.5) | |
| Height (cm) | 149.2 (21.2) | 152.7 (16.5) | |
| Lower leg length (cm) | 36.2 (6.0) | 36.9 (5.3) | |
| Resting ankle joint angle (°) | −26.2 (5.7)* | −20.8 (4.5) | 1.06 |
| MTU length (normalized)a | 1.06 (0.04)* | 1.10 (0.04) | 1.00 |
| GM muscle belly length (normalized)a | 0.53 (0.08)* | 0.59 (0.04) | 0.98 |
| GM muscle belly length (% of MTU length) | 50 (6) | 54 (4) | 0.80 |
| Achilles tendon length (normalized)a | 0.53 (0.06) | 0.51 (0.05) | −0.37 |
| Achilles tendon length (% of MTU length) | 50 (6) | 46 (4) | −0.80 |
| Achilles tendon cross-sectional area (mm2) | 44.5 (10.6) | 52.3 (10.5) | 0.74 |
Values are reported as mean (standard deviation). CP cerebral palsy; TD typically developing; MTU muscle-tendon unit; GM gastrocnemius medialis
anormalized to lower leg length
*significantly different from TD, p < .05
Fig. 1Measurement setup for the calculation of gastrocnemius medialis muscle and Achilles tendon morphological properties. Numbers 1 and 3 on the lower leg indicate the tape strips used to calculate the muscle belly and tendon length, number 2 shows the tape strip placed as a visual aid to determine 50% of the muscle belly length, and number 4 indicates the tape strip that was utilized as a marker to assess the Achilles tendon cross-sectional area
Fig. 2Ultrasound images used to assess the GM muscle belly and Achilles tendon lengths, based on the US-tape method of Barber et al. 2011. The dashed lines show the distance from the superficial aspect of the condyle (a) and the most distal aspect of the muscle-tendon junction (b) to the tape (black shadow), whereby the white arrows indicate the US depth
Fig. 3Ultrasound image of the GM muscle showing determination of muscle thickness (dotted line), fascicle length (solid line), and pennation angle (PA). Muscle thickness was measured at 50% of the muscle belly length (dashed line) determined from the echo of the applied tape (black shadow on the right side)
Fig. 4Transverse US image showing the manually outlined Achilles tendon cross-sectional area (white shape)
Muscle morphology of the gastrocnemius medialis in children with cerebral palsy and typically developing children
| CP | TD | Effect size | |
|---|---|---|---|
| Fascicle length (cm) | 3.4 (1.0)* | 4.4 (0.8) | 1.12 |
| Fascicle length (normalized to MTU) | 0.09 (0.02)** | 0.11 (0.02) | 1.31 |
| Fascicle length (normalized to muscle belly length) | 0.19 (0.04) | 0.20 (0.03) | 0.29 |
| Pennation angle (°) | 21.9 (2.9)** | 18.1 (2.7) | −1.36 |
| Muscle thickness (cm) | 1.3 (0.4) | 1.3 (0.2) | 0.00 |
Values are reported in mean (standard deviation). CP cerebral palsy; TD typically developing; MTU muscle-tendon unit
*significantly different from TD, p < .05
**significantly different from TD, p < .01
Previous botulinum toxin application (number, past months before study participation) in the medial gastrocnemius in the study participants with mild spastic CP
| Subject | Number of injections | Months past from last injection |
|---|---|---|
| 1 | none | – |
| 2 | 7 | 9 |
| 3 | none | – |
| 4 | 1 | 9 |
| 5 | none | – |
| 6 | 2 | 96 |
| 7 | none | – |
| 8 | none | – |
| 9 | 4 | 72 |
| 10 | 1 | 84 |